By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Small Business Innovation Research (SBIR) 

Regional Area      U.S.A.
Phone: 800-382-4634 Fax: 800-462-4128


Company News
zuChem Receives Phase II SBIR Award From NIH Chicago, IL 4/29/2015 10:36:48 AM
Rheonix, Inc. Receives $1.5 Million SBIR Phase II Grant From The National Institute Of Dental And Craniofacial Research Of The NIH To Complete Development Of A Rapid Point-Of-Care Test For HIV/AIDS 4/13/2015 10:40:20 AM
DiscoveryBioMed Is Awarded A New Phase II SBIR Grant Award To Develop New Medicines To Fight The Diabetes And Obesity Epidemic In The U.S. And Globally 4/8/2015 10:52:57 AM
HealthMyne Receives Phase II SBIR Grant To Develop A Novel Imaging And Analytics Platform For Oncology 4/7/2015 2:36:43 PM
Immunomic Therapeutics Awarded SBIR Grant From NIH For Nanoplasmid Peanut Allergy Vaccine Development 3/31/2015 11:01:31 AM
T3D Therapeutics Awarded SBIR Phase 2 Grant From National Institute on Aging For Alzheimer's Disease Drug Testing 3/25/2015 1:45:28 PM
Highland Instruments, Inc. , Announces New Award Of Small Business Innovation Research (“SBIR”) Grant For Clinical Evaluation Of Noninvasive Neural Stimulation Technology 3/16/2015 12:50:37 PM
AxioMx Receives SBIR Grant To Develop Multiplex Antigen Screening Technology 3/10/2015 10:43:39 AM
Meridian Life Science Awarded SBIR II By CDC To Develop Rotavirus Vaccine 12/2/2014 9:00:44 AM
Altor BioScience Corporation Initiates Clinical Development Of Its Novel IL-15 Super Agonist ALT-803 For Relapsed / Refractory Multiple Myeloma Supported By A Newly Awarded Phase 2 SBIR Grant From National Cancer Institute 11/4/2014 10:22:56 AM